A Rare Case of Kikuchi-Fujimoto Disease in an Indian Female
Shubham Darda
Department of Medicine, SBKS MI&RC, Vadodara, India
Aarjuv Majmundar *
Department of Medicine, SBKS MI&RC, Vadodara, India.
Puneet Upadhyay
Department of Medicine, SBKS MI&RC, Vadodara, India.
Harshita H. Nouni
Department of Medicine, SBKS MI&RC, Vadodara, India.
Sucheta Lakhani
Department of Microbiology, SBKS MI&RC, Vadodara, India.
Jitendra D. Lakhani
Department of Medicine, SBKS MI&RC, Vadodara, India.
*Author to whom correspondence should be addressed.
Abstract
Kikuchi-Fujimoto disease is a self-limiting illness characterised by non-specific symptoms, most commonly reported symptoms being fever and lymphadenopathy. Unknown in its cause, Kikuchi-Fujimoto disease (KFD) is a benign, uncommon disorder usually presenting under the age of 30 years in women. This disease is mainly seen in Asian population mainly in Japan but it is rare in Indian population. The etiological cause of this disease remains unknown. This condition needs to differentiated from other closely resembling conditions such as tuberculosis, lymphoma, Systemic Lupus Erythematosus (SLE) and adenocarcinoma. The physician needs to be aware about this condition to avoid misdiagnosis and improper treatment. This case report is about a female of age 26 years who was diagnosed as having Kikuchi Fujimoto Disease on the basis of clinical and biopsy findings.
Keywords: Kikuchi-Fujimoto syndrome, benign, lymphoma, tuberculosis, lymphadenopathy
How to Cite
Downloads
References
Rammohan A, Cherukuri SD, Manimaran AB, Manohar RR, Naidu RM. Kikuchi-Fujimoto Disease: A Sheep in Wolf's Clothing. J Otolaryngol Head Neck Surg. 2012;41(3):222–26. PMID 22762705.
Kaushik V, Malik TH, Bishop PW, Jones PH. Histiocytic necrotising lymphadenitis (Kikuchi's disease): A rare cause of cervical lymphadenopathy. Surgeon. 2004; 2(3):179–82.
DOI:10.1016/s1479-666x(04)80084-2. PMID 15570824.
Bosch X, Guilabert A. Kikuchi-fujimoto disease. Orphanet J Rare Dis. 2006;1:18.
DOI:10.1186/1750-1172-1-18. PMC 1481509. PMID 16722618.
Bosch X, Guilabert A, Miquel R, Campo E. Enigmatic Kikuchi-Fujimoto disease: A comprehensive review. Am. J. Clin. Pathol. 2004;122(1):141–52.
DOI:10.1309/YF08-1L4T-KYWV-YVPQ. PMID 15272543.
Kikuchi M. Lymphadenitis showing focal reticulum cell hyperplasia with nuclear debris and phagocytes. Acta Hematol Jpn. 1972;35:379–80.
Abdu Ahmed BA, MedSci*; Pajkrt Dasja MD, PhD, MBA†; Bijker, Else M. MD, PhD‡. Kikuchi Disease in children: Case report and review of the literature. The Pediatric Infectious Disease Journal. 2022; 41(3):199-204.
Perry AM, Choi SM. Kikuchi-fujimoto disease: A review. Arch Pathol Lab Med. 2018;142:1341–6.
Lahma J, Arkoubi Z, Hejjouji R, Nitassi S, El Ayoubi A, Bencheikh R, et al. About a rare disease misdiagnosed as malignant lymphoma or tuberculosis: Kikuchi-Fujimoto’s disease. Pan Afr Med J. 2018; 31:1–5.
Lin HC, Su CY, Huang CC, Hwang CF, Chien CY. Kikuchi’s disease: A review and analysis of 61 cases. Otolaryngol Head Neck Surg. 2003;128:650–3.
Loachim HL, Ratech H. Loachim's lymph node pathology. 3rd ed. New York: Lippincott Williams & Wilkins; 2002.
Menasce LP, Banerjee SS, Edmondson D, Harris M. Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease): Continuing diagnostic difficulties. Histopathology. 1998;33(3):248–254.
Jaseb K, Nameh Goshay Fard N, Rezaei N, Sadeghian S, Sadeghian S. COVID-19 in a case with Kikuchi-Fujimoto disease. Clin Case Rep. 2021;(3):1279-1282.
Al Ghadeer HA, AlKadhem SM, AlMajed MS, AlAmer HM, AlHabeeb JA, Alomran SH, et al. Kikuchi-Fujimoto Disease Following COVID-19. Cureus. 2022; (1):e21049.
Tan HM, Hue SS, Wee A, See KC. Kikuchi-fujimoto disease post COVID-19 vaccination: Case report and review of literature. Vaccines (Basel). 2021;9(11).
Racette SD, Alexiev BA, Angarone MP, Bhasin A, Lima K, Jennings LJ, et al. Kikuchi-Fujimoto disease presenting in a patient with SARS-CoV-2: a case report. BMC Infect Dis. 2021;21(1):740.
Soub HA, Ibrahim W, Maslamani MA, A Ali G, Ummer W, Abu-Dayeh A. Kikuchi-fujimoto disease following SARS CoV2 vaccination: Case report. IDCases. 2021; 25:e01253.
Guan Y, Xia X, Lu H. Kikuchi-fujimoto disease following vaccination against COVID-19. J Hematop. 2022;(1):21-23.
Alam H, Saeed MO, Saeed AB, Zaidi A. Kikuchi disease. J Pak Med Assoc. 2015;65(12):1349-50.
Lamzaf L, Harmouche H, Maamar M, Adnaoui M, Aouni M, Tazi Mezalek Z. Kikuchi-fujimoto disease: Report of 4 cases and review of the literature. Eur Ann Otorhinolaryngol Head Neck Dis. 2014; 131(6):329-32.
Kuo TT. Kikuchi's disease (histiocytic necrotizing lymphadenitis). A clinicopathologic study of 79 cases with an analysis of histologic subtypes, immunohistology, and DNA ploidy. Am J Surg Pathol. 1995;19(7):798-809.
Iguchi H, Sunami K, Yamane H, et al. Apoptotic cell death in Kikuchi's disease: A TEM study. Acta Otol Laryngol. 1998;118:250–3. [PubMed] [Google Scholar]
Kucukardali Y, Solmazgul E, Kunter E, et al. Kikuchi-Fujimoto disease: Analysis of 244 cases. Clin Rheumatol. 2007;26:50–54
Litwin MD, Kirkham B, Henderson DR, Milazzo SC. Histiocytic necrotising lymphadenitis in systemic lupus erythematosus. Ann Rheum Dis. 1992; 51(6):805–807.
Hsiang-Cheng C, Jenn-Huang L, Guo-Shu H, et al. Systemic lupus erythematosus with simultaneous onset of Kikuchi-Fujimoto's disease complicated with antiphospholipid syndrome: A case report and review of the literature. Rheumatol Int. 2005;254:303–306.
Leyral C, Camou F, Perlemoine C, Caubet O, Pellegrin JL, Viallard JF. Pathogenic links between Kikuchi's disease and lupus: A report of three new cases [in French].Rev Med Interne 2005;268: 651–655.